Michael Chicoine, MD
Neurological Surgery · Saint Louis, MONPI 1346268984
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,350 of the $12,678 with a category attached, or 89.5%. Medtronic accounts for 91.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $4,688 and has fallen 97.6% since, to $114 in 2025.
Across 30 payments — averaging $422.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- Mizuho America, Inc.$238
- Integra Lifesciences Corporation$210
- Stryker$149
- Omniscient Neurotechnology America Ltd$138
- GT Medical Technologies, Inc$114
- plus $193 from 5 others
What the payments were for
- Consulting fees$11,35090%
- Food & beverage$1,32810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 10 | $11,636 |
| Mizuho America, Inc. | 1 | $238 |
| Integra Lifesciences Corporation | 3 | $210 |
| Stryker | 9 | $149 |
| Omniscient Neurotechnology America Ltd | 1 | $138 |
| GT Medical Technologies, Inc | 1 | $114 |
| Zimmer Biomet | 1 | $75 |
| Monteris Medical Corporation | 1 | $54 |
| Johnson & Johnson | 1 | $23 |
| Imperative Care, Inc | 1 | $21 |
| UCB, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- StealthStation$4,550
- STEALTHSTATION S8 PLATFORM$4,271
- CODMAN CERTAS$146
- CUSA CLARITY$146
- CODMAN HAKIM$146
- DURASEAL EXACT SPINAL SEALANT SYSTEM$146
- Quicktome$138
- GammaTile$114
How this compares
$12,678 in reported general payments places this provider in the 75th percentile of 172 neurological surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 13 | $364 |
| Cetirizine Hcl | 17 | $152 |
| Topiramate | 17 | $101 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Saint Louis
- Neill WrightSaint Louis$1.1M
- Wilson RaySaint Louis$586K
- Camilo MolinaSaint Louis$412K
- Paul SantiagoSaint Louis$368K
- Daniel ScodarySaint Louis$278K
- Daniel HafezSaint Louis$273K
- John OgunladeSaint Louis$220K
- Joshua OsbunSaint Louis$98K
- Adewale BakareSaint Louis$81K
- Eric LeuthardtSaint Louis$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.